October 1, 2020
Penn Researchers Discover Potential Cause of Immunotherapy-Related Neurotoxicity, Chart Path Forward
New research has uncovered the previously unknown presence of CD19 — a B cell molecule targeted by chimeric antigen receptor (CAR) T cell immunotherapy to treat leukaemia, lymphoma, and multiple myeloma — in brain cells that protect the blood-brain barrier (BBB). This discovery may potentially be the cause for neurotoxicity […]
